Your browser doesn't support javascript.
loading
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.
Patel, Minal K; Bergeri, Isabel; Bresee, Joseph S; Cowling, Benjamin J; Crowcroft, Natasha S; Fahmy, Kamal; Hirve, Siddhivinayak; Kang, Gagandeep; Katz, Mark A; Lanata, Claudio F; L'Azou Jackson, Maïna; Joshi, Sudhir; Lipsitch, Marc; Mwenda, Jason M; Nogareda, Francisco; Orenstein, Walter A; Ortiz, Justin R; Pebody, Richard; Schrag, Stephanie J; Smith, Peter G; Srikantiah, Padmini; Subissi, Lorenzo; Valenciano, Marta; Vaughn, David W; Verani, Jennifer R; Wilder-Smith, Annelies; Feikin, Daniel R.
Affiliation
  • Patel MK; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland. Electronic address: patelm@who.int.
  • Bergeri I; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.
  • Bresee JS; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, USA.
  • Cowling BJ; School of Public Health, The University of Hong Kong, Pokfulam, Hong Kong, China.
  • Crowcroft NS; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.
  • Fahmy K; World Health Organization Regional Office for the Eastern Mediterranean, Monazamet El Seha El Alamia Str, Extension of Abdel Razak El Sanhouri Street, P.O. Box 7608, Nasr City, Cairo 11371, Egypt.
  • Hirve S; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.
  • Kang G; Christian Medical College, Ida Scudder Road, Vellore, Tamil Nadu 632004, India.
  • Katz MA; World Health Organization Regional Office of Europe, UN City, Marmorvej 51, Copenhagen DK-2100, Denmark.
  • Lanata CF; Instituto de Investigación Nutricional, Av. la Molina 1885, La Molina 15024, Peru.
  • L'Azou Jackson M; The Coalition for Epidemic Preparedness Innovations (CEPI), Gibbs building, 215 Euston Rd, Bloomsbury, London NW1 2BE, United Kingdom.
  • Joshi S; World Health Organization Regional Office for South-East Asia, World Health House, Indraprastha Estate, Mahatma Gandhi Marg, New Delhi 110 002, India.
  • Lipsitch M; Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, USA.
  • Mwenda JM; World Health Organization Regional Office for Africa, Cité du Djoué, P.O. Box 06, Brazzaville, Republic of Congo.
  • Nogareda F; Consultant to the Pan American Health Organization, 525 23rd Street NW, Washington, DC 20037, USA.
  • Orenstein WA; Emory Vaccine Center, 954 Gatewood Road, Atlanta, GA 30329, USA.
  • Ortiz JR; Center for Vaccine Development & Global Health, University of Maryland School of Medicine, 685 W. Baltimore St., Room #480, Baltimore, MD 21201, USA.
  • Pebody R; World Health Organization Regional Office of Europe, UN City, Marmorvej 51, Copenhagen DK-2100, Denmark.
  • Schrag SJ; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, USA.
  • Smith PG; MRC International Epidemiology & Statistics Group, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom.
  • Srikantiah P; Bill & Melinda Gates Foundation, 500 5th Ave N., Seattle, WA 98109, USA.
  • Subissi L; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.
  • Valenciano M; Epiconcept, 25 rue de Titon, Paris 75011, France.
  • Vaughn DW; Bill & Melinda Gates Foundation, 500 5th Ave N., Seattle, WA 98109, USA.
  • Verani JR; U.S. Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, USA.
  • Wilder-Smith A; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.
  • Feikin DR; World Health Organization, 20 Avenue Appia, Geneva 1211, Switzerland.
Vaccine ; 39(30): 4013-4024, 2021 07 05.
Article in En | MEDLINE | ID: mdl-34119350

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Clinical_trials / Guideline Limits: Humans Language: En Journal: Vaccine Year: 2021 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Clinical_trials / Guideline Limits: Humans Language: En Journal: Vaccine Year: 2021 Document type: Article Country of publication: